KYVOR - A Precision Diagnosis for every kind of Cancer
KYVOR - A Precision Diagnosis for every kind of Cancer
Genomics, a branch of molecular biology is the study of structure, function, evolution and mapping of genomes. The genetic insights help devise precise and tailored treatment programs to target mutations that may be found in each tumor’s DNA profile.
Most drug prescriptions are largely based on the process of evaluating the effects of different medications until one is found most successful, instead of being based on accurate biomarker data. Patients who share a similar cancer diagnosis do not respond to the same pharmacological intervention. However, with the advance of molecular diagnostics using Next Generation Sequencing (NGS), accompanied by a subsequent increase in the understanding of the genetic mechanisms underlying health conditions, an accurate approach can be taken towards decision making for cancer treatments.
Genome based cancer treatment is a shift from an organ-focused like Breast cancer, Lung cancer, Colon cancer to a gene-focused approach like HER2mutations, EGFRmutations that has enabled in increasing survival rates for a variety of cancers.
Cancer is a disease of the genome and as more is learned about cancer tumours, the more we are understanding that each tumour has its own set of genetic changes.
Understanding these genetic changes that result in cancer is leading to more effective treatment strategies that are tailored to the genetic profile of each patient’s cancer.
Kyvor Genomics, Inc is a genome intelligence company, with a disruptive objective that “The War Against Cancer Can Be Won” using a one-of-a-kind proprietary product, an individualized cancer theragnostic* test – CANLYTx™ (Cancer + Analytics).
CANLYTx™ (CANCER + ANALYTICS) is a molecular data analytics and simulation engine that explores the whole exome data of the patient’s tumor DNA to demystify the complex genomic anomalies unique to that cancer. An individualized treatment regimen based on these genomic findings is presented in an elaborate report to the clinicians.
58 yo, Professor of Pharmacology at Aix-Marseille University, certified in Neurology, Psychiatry and Medical Biology. He owns a PhD in Human Biology as well as a MBA from Ecole Centrale Paris. He is currently Head of the Clinical Pharmacology & Pharmacovigilance Department, Marseille University Hospital (Ap-Hm), Head of the Integrated Pharmacology and Clinical Interface Sector, Institut Neurosciences Timone, UMR AMU-INSERM 1106, and coordinator of the University Hospital Federation DHUNE, COEN center on neurodegenerative disorders and aging (www.dhune.org).
At the national level, he is a Member of the Working Group French National Plan for Rare Diseases, Member of the National Steering Committee French National Plan for Neurodegenerative Diseases and of the scientific committee of CNS ITMO Aviesan. He also is Vice President of the scientific council of CSFRS (Ecole Militaire, Paris).
Olivier Blin is a Past member of the Board of the French Minister of Health (2004-05), Founding Vice-President of Eurobiomed Cluster, Past Head of Unit Physician, CNS, GSK, Shanghai (2011-13) and Past Visiting Professor at Imperial College London (2012-13).
Dr. Boomeswaran is Pioneer member among the Indian Doctors Community in UK/Ireland and clinical operations in St. Johns of God Hospitallers, Ireland and a practicing Radiologist in Lugh Medical and Research Centre Ireland. Founder of (LIMIS) Lugh Institute for Medical Imaging Studied Ireland, Jersey and a guest lecturer and a speaker in RCSI and University of Zurich in Switzerland. Dr. Boomee is the sitting Secretary of Confederation of Indian Community in Ireland (CICI).
He also plays as one of the directors in Infini International School in Kanchipuram, India.
Kyvor has an active presence in countries all over the world, as we aim to be at the forefront of molecular theragnostics. We work towards bringing our technology and care to patients in every corner of the world, as we believe that the war against cancer can be won.
Consult a doctor, undergo genetic counselling to take a genomic test - Kyvor will help you choose the most reliable path for your cancer treatment.
